Lv2
164 积分 2024-08-07 加入
Rethinking Multiple Myeloma Treatment: The Biological and Clinical Insights Guiding Immune-Based Combinations
26天前
已完结
SIRT2: Controversy and multiple roles in disease and physiology
1个月前
已完结
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer
1个月前
已完结
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
1个月前
已完结
Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors
2个月前
已完结
Structural Basis for DNA Damage–Dependent Poly(ADP-ribosyl)ation by Human PARP-1
2个月前
已完结
The RNA-binding protein HuR in human cancer: A friend or foe?
3个月前
已完结
Discovery and Optimization of a Non-Nucleoside-Based Series of Inhibitors of 2′-Deoxynucleoside 5′-Monophosphate Glycosidase (DNPH1)
3个月前
已完结
Discovery and Characterization of Diverse Non-nucleotide Inhibitors of DNPH1 Using an Integrated Hit Finding Strategy
3个月前
已完结
A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors
4个月前
已完结
皖公网安备34019202002308
